Lupin has received Establishment
Inspection Report (EIR) for its Pithampur (Unit -3) facility. The inspection was conducted between 08 October 2018
to 18 October 2018.
Lupin's Pithampur Unit-3 is involved in the manufacture of Metered Dose Inhalers (MDis), Dry Powder Inhalers (DPis) and Topical Formulations for the regulated markets.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
